Plain-English translation of NCT06894784 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Phase 3 โ Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing whether semaglutide โ a medication that helps your body manage blood sugar โ and another medication called empagliflozin work better together or separately when combined with an automated insulin pump (often called a closed-loop system). The study will compare these two medications to placebo (a dummy medication) to see which combination helps you keep your blood sugar in a healthy range most of the time.
Even with insulin pumps, many people with type 1 diabetes struggle to keep their blood sugar stable throughout the day. Researchers believe adding these medications to pump therapy might help reduce high and low blood sugar episodes and improve overall diabetes control.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You'll start with a screening visit and a 12-week period where you gradually increase the semaglutide dose to find what works best for you. Then you'll go through four separate four-week periods, trying different combinations of the two medications and placebo while using your insulin pump as usual. Throughout the study, you'll check your blood sugar regularly with your pump and work with the research team to monitor how well each combination works for you.
AI-generated summary from trial data ยท Jun 22, 2026 ยท Not medical advice
Canada